FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to potentiating preparation for radiation therapy, which as effective component contains uracyl derivative, represented by formula (1) where R1 represents halogen atom or cyanogroup; and R2 represents (4-8)-member heterocyclic group, which has from 1 to 3 nitrogen atoms and optinally has as substituent C1-C4 alkyl group, iminogroup, hydroxyl group, hydroxymethyl group, methansulphonyloxy group or aminogroup; amidinothiogroup, in which hydrogen atom, bound to nitrogen atom, can be substituted by C1-C4 alkyl group; guanidinogroup, in which hydrogen atom, bound to nitrogen atom, can be substituted by C1-C4 alkyl group or cyanogroup; C1-C4 alkylamidinogroup; or 1-pyrrolidinylmethyl group or its pharmaceutically acceptable salt. Invention also relates to method of radiation therapy potentiation, and to method of cancer treatment, which include introduction of described above uracyl derivative of formula (1) to patient who needs it.
EFFECT: invention ensures reduction of negative effect of radiation therapy, reduction of radiotherapy dose and enhancement of therapeutic effect.
18 cl, 3 tbl, 1 dwg, 4 ex
Title |
Year |
Author |
Number |
REINFORSING AGENT FOR RADIATION THERAPY, WHICH INCLUDES PYRIDINE DERIVATIVE AS ACTIVE INGREDIENT |
2006 |
|
RU2415670C2 |
ANTICANCER AGENT AND METHOD FOR PREDICTION OF THERAPEUTIC EFFECT FOR PATIENTS WITH COLON CANCER AND RECTUM GENE MUTATION KRAS |
2012 |
- Ito Masanobu
- Okabe Khiroyuki
|
RU2585528C2 |
ANTICANCER MEDICINE, CONTAINING α,α,α-TRIFLUOROTHYMIDINE AND THYMIDINE PHOSPHORYLASE INHIBITOR |
2006 |
- Emura Tomokhiro
- Mita Akira
|
RU2394581C2 |
APPLICATION OF TRISUBSTITUTED GLYCEROL COMPOUNDS FOR TREATMENT OF RADIOLESIONS |
2007 |
- Rikhter Vol'Fgang
- Veber Lutts
|
RU2448973C2 |
COMBINED THERAPY FOR CANCER TREATMENT |
2015 |
- Bao, Xingfeng
- Albu, Diana
- Woodall-Jappe, Mary
|
RU2708374C2 |
USE OF SESQUITERPENE LACTONE COMPOUND IN PREPARING DRUGS FOR RELIEVING RADIATION-INDUCED INJURIES |
2021 |
- Chen, Yue
- Tsaj, Dunpo
- Bao, Shitsi
- Chzhan, Syuemej
- Chen, Tszin
- Gun, Tszyanmyao
- Go, Tszyanshuan
- Li, Tszin
|
RU2822760C1 |
COMBINATION OF TRIFLURIDINE/TIPIRACIL HYDROCHLORIDE, ANTITUMOR PLATINUM COMPLEX, AND MODULATOR OF CONTROL POINTS OF IMMUNE RESPONSE |
2018 |
- Abastado Jean-Pierre
- Amellal Nadia
- Bruno Alain
- Burbridge Michael Frank
- Cattan Valerie
- Leger Catherine
|
RU2778887C2 |
REMEDY POTENTIATING ANTI-TUMOUR EFFECT, AND ANTI-TUMOUR REMEDY |
2004 |
|
RU2334517C2 |
ANTITUMOUR AGENT INCLUDING IRINOTECAN HYDROCHLORIDE HYDRATE |
2014 |
|
RU2657604C2 |
LOW-DOSE ANTITUMOR AGENT INCLUDING IRINOTECAN HYDROCHLORIDE HYDRATE |
2014 |
|
RU2668125C2 |